Trials / Unknown
UnknownNCT04675060
Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules
A Study of the Effect of High-fat Meal on the Pharmacokinetics of Oral TQ-B3139 Capsules in Patients With Solid Tumor
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to evaluate the effect of high-fat meal on the pharmacokinetics of TQ-B3139 capsules in patients with solid tumor
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TQ-B3139 capsules | TQ-B3139 capsules administered 600mg orally, twice daily in 28-day cycle. |
Timeline
- Start date
- 2021-02-23
- Primary completion
- 2022-03-01
- Completion
- 2022-03-01
- First posted
- 2020-12-19
- Last updated
- 2021-04-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04675060. Inclusion in this directory is not an endorsement.